01.
European and International Financing.
Alignment of companies’ R&D roadmap with available European and International financing tools (grants and tenders), positioning and follow-up in the new European R&D&I financial framework for 2021-2027, and the Next Generation EU recovery fund.
02.
National Financing.
Business financing of R&D through different kinds of public tenders at both National and Regional levels. These are soft grants and loans for all kinds of companies and activities.
03.
Tax Breaks.
Tax incentive applicable to Corporation Tax, reducing it by up to 100%. Applicable generation potential of up to 59% of R&D expenses.
04.
Fiscal Rebates.
For companies that do not have to pay corporation tax or want to apply an unlimited deduction, the law allows them to request the full monetisation of the generated deduction.
05.
Research Personnel.
This is a non-tax fiscal incentive, which allows companies to write down around 10% of the gross salary of subsidised personnel.
06.
Patent Box.
Fiscal incentive that makes it possible to reduce income tax by transferring certain intangible assets created by the company, reducing 60% of the net income from said income sources.